Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May;44(5):765-775.
doi: 10.1007/s00259-016-3578-z. Epub 2016 Nov 29.

Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions

Christian Uprimny  1 , Alexander Stephan Kroiss  2 , Clemens Decristoforo  2 , Josef Fritz  3 , Boris Warwitz  2 , Lorenza Scarpa  2 , Llanos Geraldo Roig  2 , Dorota Kendler  2 , Elisabeth von Guggenberg  2 , Jasmin Bektic  4 , Wolfgang Horninger  4 , Irene Johanna Virgolini  2
Affiliations

Early dynamic imaging in 68Ga- PSMA-11 PET/CT allows discrimination of urinary bladder activity and prostate cancer lesions

Christian Uprimny et al. Eur J Nucl Med Mol Imaging. 2017 May.

Abstract

Purpose: PET/CT with 68Ga-labelled prostate-specific membrane antigen (PSMA)-ligands has been proven to establish a promising imaging modality in the work-up of prostate cancer (PC) patients with biochemical relapse. Despite a high overall detection rate, the visualisation of local recurrence may be hampered by high physiologic tracer accumulation in the urinary bladder on whole body imaging, usually starting 60 min after injection. This study sought to verify whether early dynamic 68Ga-PSMA-11 (HBED-CC)PET/CT can differentiate pathologic PC-related tracer uptake from physiologic tracer accumulation in the urinary bladder.

Methods: Eighty consecutive PC patients referred to 68Ga -PSMA-11 PET/CT were included in this retrospective analysis (biochemical relapse: n = 64; primary staging: n = 8; evaluation of therapy response/restaging: n = 8). In addition to whole-body PET/CT acquisition 60 min post injection early dynamic imaging of the pelvis in the first 8 min after tracer injection was performed. SUVmax of pathologic lesions was calculated and time-activity curves were generated and compared to those of urinary bladder and areas of physiologic tracer uptake.

Results: A total of 55 lesions consistent with malignancy on 60 min whole body imaging exhibited also pathologic 68Ga-PSMA-11 uptake during early dynamic imaging (prostatic bed/prostate gland: n = 27; lymph nodes: n = 12; bone: n = 16). All pathologic lesions showed tracer uptake within the first 3 min, whereas urinary bladder activity was absent within the first 3 min of dynamic imaging in all patients. Suvmax was significantly higher in PC lesions in the first 6 min compared to urinary bladder accumulation (p < 0.001). In the subgroup of PC patients with biochemical relapse the detection rate of local recurrence could be increased from 20.3 to 29.7%.

Conclusions: Early dynamic imaging in 68Ga-PSMA-11 PET/CT reliably enables the differentiation of pathologic tracer uptake in PC lesions from physiologic bladder accumulation. Performance of early dynamic imaging in addition to whole body imaging 60 min after tracer injection might improve the detection rate of local recurrence in PC patients with biochemical relapse referred for 68Ga-PSMA-11 PET/CT.

Keywords: 68Ga-PSMA-11 PET/CT; Biochemical recurrence; Early dynamic imaging; Prostate cancer.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Curr Urol Rep. 2016 Mar;17 (3):18 - PubMed
    1. Eur Radiol. 2009 Mar;19(3):761-9 - PubMed
    1. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1611-20 - PubMed
    1. Crit Rev Oncol Hematol. 2012 Oct;84(1):109-21 - PubMed
    1. AJR Am J Roentgenol. 2010 Jun;194(6):1427-33 - PubMed

MeSH terms

LinkOut - more resources